Questões de Inglês - Advérbios e conjunções | Adverbs and conjunctions para Concurso

Foram encontradas 420 questões

www.qconcursos.com
Q2254454
Inglês Advérbios e conjunções | Adverbs and conjunctions ,
Ano: 2006 Banca: FCC Órgão: BACEN Prova: FCC - 2006 - BACEN - Analista do Banco Central - Área 3 - Conhecimentos Específicos |
Q2254454 Inglês
Senate Passes Plan to Cut $35 Billion From Deficit

By Jonathan Weisman
Washington Post Staff Writer
Friday, November 4, 2005; A01

    The Senate approved sweeping deficit-reduction legislation last night that would save about $35 billion over the next five years by cutting federal spending on prescription drugs, agriculture supports and student loans, while clamping down on fraud in the Medicaid program.
     The measure would also open Alaska's Arctic National Wildlife Refuge to oil drilling, a long-sought goal of the oil industry that took a major step forward after years of political struggle. A bipartisan effort to strip the drilling provision narrowly failed.
    The Senate bill, which passed 52 to 47, is the first in nearly a decade to tackle the growth of entitlement spending, the part of the federal budget that rises automatically based on set formulas and population changes.
     It would shave payments to some farmers by 2.5 percent, while eliminating a major cotton support program and trimming agriculture conservation spending. A proposal to limit payments to rich farmers failed yesterday. The measure passed largely along party lines, with only two Democrats voting for it and five Republicans voting against it.
     Yesterday's action is part of an effort by congressional Republicans to demonstrate fiscal discipline after widespread complaints of profligate spending on Capitol Hill. ....51.... many Democrats and some moderate Republicans are concerned that the effort may go too far, prominent Republicans in the Senate and House said the cuts were necessary to slow the rate of spending and control a deficit projected to total $314 billion by the end of the fiscal year.
      During a speech yesterday, former House majority leader Tom Delay (R-Tex) repeatedly apologized for excessive spending by Congress, including recent highway legislation that was ....52.... with lawmakers’ pet projects. After noting that House Republicans have voted to cut taxes every year since winning the majority in 1994, DeLay acknowledged, “Our record on spending has not been as consistent, ....53.... .”

(Adapted from washingtonpost.com)
Na questão, a palavra que preenche corretamente a lacuna é
Alternativas
Q2254265
Inglês Advérbios e conjunções | Adverbs and conjunctions ,
Ano: 2006 Banca: FCC Órgão: BACEN Provas: FCC - 2006 - BACEN - Analista do Banco Central - Área 1 - Prova 2 - Conhecimentos Específicos | FCC - 2006 - BACEN - Analista do Banco Central - Área 2 - Conhecimentos Específicos |
Q2254265 Inglês
The Internet at Risk

    Some 12,000 people convened last week in Tunisia for a United Nations conference about the Internet. Many delegates want an end to the U.S. Commerce Department's control over the assignment of Web site addresses (for example, http://www.washington-%20post.com/ ) and e-mail accounts (for example, [email protected]). The delegates' argument is that unilateral U.S. control over these domain names reflects no more than the historical accident of the Internet's origins. Why should the United States continue to control the registration of French and Chinese Internet addresses? It doesn't control the registration of French and Chinese cars, whatever Henry Ford's historic role in democratizing travel was.
    The reformers' argument is attractive in theory and dangerous in practice. In an ideal world, unilateralism should be avoided. But in an imperfect world, unilateral solutions that run efficiently can be better than multilateral ones that  ....51....
        The job of assigning domain names offers huge opportunities for abuse. ....52.... controls this function can decide to keep certain types of individuals or organizations offline (dissidents or opposition political groups, for example). Or it can allow them on in exchange for large fees. The striking feature of U.S. oversight of the Internet is that such abuses have not occurred.
        It's possible that a multilateral overseer of the Internet might be just as efficient. But the ponderous International Telecommunication Union, the U.N. body that would be a leading candidate to take over the domain registry, has a record of resisting innovation - including the advent of the Internet. Moreover, a multilateral domain-registering body would be caught between the different visions of its members: on the one side, autocratic regimes such as Saudi Arabia and China that want to restrict access to the Internet; on the other side, open societies that want low barriers to entry. These clashes of vision would probably make multilateral regulation inefficiently political. You may say that this is a fair price to pay to uphold the principle of sovereignty. If a country wants to keep certain users from registering domain names (Nazi groups, child pornographers, criminals), then perhaps it has a right to do so. But the clinching argument is that countries can exercise that sovereignty to a reasonable degree without controlling domain names. They can order Internet users in their territory to take offensive material down. They can order their banks or credit card companies to refuse to process payments to unsavory Web sites based abroad. Indeed, governments' ample ability to regulate the Internet has already been demonstrated by some of the countries pushing for reform, such as authoritarian China. The sovereign nations of the world have no need to wrest control of the Internet from the United States, because they already have it.

(Adapted from Washington Post, November 21, 2005; A14)
Ainda no primeiro parágrafo, os dois períodos Why should the United States continue to control the registration of French and Chinese Internet addresses? e It doesn't control the registration of French and Chinese cars, whatever Henry Ford's historic role in democratizing travel was. podem ser ligadas, sem alteração de sentido, pela conjunção
Alternativas
Q2244809
Inglês Advérbios e conjunções | Adverbs and conjunctions , Advérbios de: lugar, modo, tempo e freqüência | Adverbs of: place, manner, time and frequency ,
Ano: 2003 Banca: FCC Órgão: CVM Prova: FCC - 2003 - CVM - Inspetor |
Q2244809 Inglês

The hard cell

Thanks to politics, stem cell research in the United States is suffering. But not so in Sweden, which is poised to capture what could be the biggest new market to hit biotech in a decade.

By Stephan Herrera

February 13, 2003


New York, January 1, 2006:

Sweden announces that one of its biotechnology companies is the first in the world to enter clinical trials with a new drug that could cure Alzheimer's disease. Four years ago this type of research was all but stopped in the United States by political and ethical questions − which is ...61... Sweden now seems in the best position to capture a $25 billion market.


        Any day now, the U.S. Congress is expected to pass a sweeping new law that could dramatically inhibit researchers from working with stem cells taken from human embryos. Such cells, which can be used to grow a whole host of new cells and organs, could fundamentally change the way we treat heretofore intractable maladies like Alzheimer's disease, Parkinson's disease, cancer, stroke, liver failure, and heart disease. The only problem is that these cells by definition are derived from human embryos, many of which are cloned or come from unused fetuses collected at fertility clinics. The argument, from a certain segment of the American political spectrum, is that ...62... methods are morally wrong. They are ...63... a form of abortion or an activity that could eventually lead to human cloning.

             Those working in stem cell research say the short-term effect of the legislation will be to further chill all forms of scientific inquiry and commercialization efforts in the field. Entrepreneurs and investors are already eschewing such research − in large part because of the additional uncertainty and risk that politics introduce.

         Of the nearly 50 private stem cell companies in the United States, only a handful are still viable. Meanwhile, across the Atlantic, Sweden has avoided many of the political and ethical quagmires surrounding this type of research. It currently has 40 private stem cell companies, a number that's growing. Sweden's leading research universities have 32 percent of the world's stem cell inventory, close on the heels of the United States' 35 percent.

          Sweden, say analysts, is now in the best position to capture a worldwide market for drugs based on stem cell therapies that could grow to $25 billion in the next three to five years − nearly equal to the whole biotech industry at present. This estimate doesn't even address the market for stem cells capable of repairing damaged vital organs like the brain, heart, and kidneys. If the United States offers an object lesson of what can happen when scientific inquiry and investment capital fall victim to politics, Sweden and its leading stem cell startup, NeuroNova, offer the opposite example. How odd that the United States, which for generations has been the envy of the world for its progressive views of science and commercialization, should now have a biomedical climate chillier than a Swedish winter.

         One company feeling a lot of pain is StemCells, which at first glance seems to have it all: founding scientists include Stanford's Dr. Weissman and Fred Gage of the Salk Institute in La Jolla, California. An equally well-regarded expert in the treatment of Alzheimer's, Dr. Gage spent five years in Sweden as a researcher and now sits on a national committee on stem cell research there. The firm's chairman is Roger Perlmutter, Amgen's head of research.

       Yet over the past two years, none of management's efforts to help investors and even critics reconsider the stem cell field have worked. At press time, the stock was thinly traded and sitting in the neighborhood of 50 cents. With less than $15 million in cash, the company likely won't exist at this time next year. (CEO Martin McGlynn, who joined the firm in January 2001, would not talk to Red Herring, despite repeated efforts.)       

      Some observers on Wall Street are asking, If StemCells can't make it, who can? Geron, the only other publicly held stem cell firm to speak of, is in a fix, too. The company's stock price is also moribund, at $3.85 per share. Thanks to some capital infusions a few years ago, when money came easy, Geron still has $40 million on hand, but by the end of next year, that too will likely be gone. Once a media darling, Geron focuses on diagnostic tests and drugs derived from stem cells, a strategy that's not going well. For the nine months ended last September, revenue fell 68 percent to $955,000 and net loss widened 18 percent to $26.7 million. The company's financials were also hit hard after it terminated an agreement with Pharmacia and acquired research technology from Lynx Therapeutics, which Geron bought in a desperate attempt to be seen as something more than just a stem cell company.

     The situation is quite different, however, for Sweden's NeuroNova, which has 30 academic partners and a staff of 20. NeuroNova is working on ways to inject stem cells into the human brain to trigger a process called neurogenesis (the growth of new neural cells), which could combat diseases like Parkinson's, Alzheimer's, and even schizophrenia.

      If NeuroNova is the first to develop a drug capable of treating one of several central nervous system disorders − by far the most lucrative after heart disease products − it will have done so not because it raised more money or got more media buzz than the rest. It will have succeeded because the science is solid, and academe, government, and the investment community are supportive. Meanwhile, the United States will look on with envy and wonder how it, a country known for its entrepreneurial innovation, ever got so short-sighted.


(Adapted from http://www.redherring.com/investor/2003/02/biotech021303.html)

The underlined adverb now refers to year
Alternativas
Q2244808
Inglês Advérbios e conjunções | Adverbs and conjunctions , Advérbios de: lugar, modo, tempo e freqüência | Adverbs of: place, manner, time and frequency ,
Ano: 2003 Banca: FCC Órgão: CVM Prova: FCC - 2003 - CVM - Inspetor |
Q2244808 Inglês

The hard cell

Thanks to politics, stem cell research in the United States is suffering. But not so in Sweden, which is poised to capture what could be the biggest new market to hit biotech in a decade.

By Stephan Herrera

February 13, 2003


New York, January 1, 2006:

Sweden announces that one of its biotechnology companies is the first in the world to enter clinical trials with a new drug that could cure Alzheimer's disease. Four years ago this type of research was all but stopped in the United States by political and ethical questions − which is ...61... Sweden now seems in the best position to capture a $25 billion market.


        Any day now, the U.S. Congress is expected to pass a sweeping new law that could dramatically inhibit researchers from working with stem cells taken from human embryos. Such cells, which can be used to grow a whole host of new cells and organs, could fundamentally change the way we treat heretofore intractable maladies like Alzheimer's disease, Parkinson's disease, cancer, stroke, liver failure, and heart disease. The only problem is that these cells by definition are derived from human embryos, many of which are cloned or come from unused fetuses collected at fertility clinics. The argument, from a certain segment of the American political spectrum, is that ...62... methods are morally wrong. They are ...63... a form of abortion or an activity that could eventually lead to human cloning.

             Those working in stem cell research say the short-term effect of the legislation will be to further chill all forms of scientific inquiry and commercialization efforts in the field. Entrepreneurs and investors are already eschewing such research − in large part because of the additional uncertainty and risk that politics introduce.

         Of the nearly 50 private stem cell companies in the United States, only a handful are still viable. Meanwhile, across the Atlantic, Sweden has avoided many of the political and ethical quagmires surrounding this type of research. It currently has 40 private stem cell companies, a number that's growing. Sweden's leading research universities have 32 percent of the world's stem cell inventory, close on the heels of the United States' 35 percent.

          Sweden, say analysts, is now in the best position to capture a worldwide market for drugs based on stem cell therapies that could grow to $25 billion in the next three to five years − nearly equal to the whole biotech industry at present. This estimate doesn't even address the market for stem cells capable of repairing damaged vital organs like the brain, heart, and kidneys. If the United States offers an object lesson of what can happen when scientific inquiry and investment capital fall victim to politics, Sweden and its leading stem cell startup, NeuroNova, offer the opposite example. How odd that the United States, which for generations has been the envy of the world for its progressive views of science and commercialization, should now have a biomedical climate chillier than a Swedish winter.

         One company feeling a lot of pain is StemCells, which at first glance seems to have it all: founding scientists include Stanford's Dr. Weissman and Fred Gage of the Salk Institute in La Jolla, California. An equally well-regarded expert in the treatment of Alzheimer's, Dr. Gage spent five years in Sweden as a researcher and now sits on a national committee on stem cell research there. The firm's chairman is Roger Perlmutter, Amgen's head of research.

       Yet over the past two years, none of management's efforts to help investors and even critics reconsider the stem cell field have worked. At press time, the stock was thinly traded and sitting in the neighborhood of 50 cents. With less than $15 million in cash, the company likely won't exist at this time next year. (CEO Martin McGlynn, who joined the firm in January 2001, would not talk to Red Herring, despite repeated efforts.)       

      Some observers on Wall Street are asking, If StemCells can't make it, who can? Geron, the only other publicly held stem cell firm to speak of, is in a fix, too. The company's stock price is also moribund, at $3.85 per share. Thanks to some capital infusions a few years ago, when money came easy, Geron still has $40 million on hand, but by the end of next year, that too will likely be gone. Once a media darling, Geron focuses on diagnostic tests and drugs derived from stem cells, a strategy that's not going well. For the nine months ended last September, revenue fell 68 percent to $955,000 and net loss widened 18 percent to $26.7 million. The company's financials were also hit hard after it terminated an agreement with Pharmacia and acquired research technology from Lynx Therapeutics, which Geron bought in a desperate attempt to be seen as something more than just a stem cell company.

     The situation is quite different, however, for Sweden's NeuroNova, which has 30 academic partners and a staff of 20. NeuroNova is working on ways to inject stem cells into the human brain to trigger a process called neurogenesis (the growth of new neural cells), which could combat diseases like Parkinson's, Alzheimer's, and even schizophrenia.

      If NeuroNova is the first to develop a drug capable of treating one of several central nervous system disorders − by far the most lucrative after heart disease products − it will have done so not because it raised more money or got more media buzz than the rest. It will have succeeded because the science is solid, and academe, government, and the investment community are supportive. Meanwhile, the United States will look on with envy and wonder how it, a country known for its entrepreneurial innovation, ever got so short-sighted.


(Adapted from http://www.redherring.com/investor/2003/02/biotech021303.html)

Para responder à questão, assinale, na folha de respostas, a letra correspondente a alternativa que preenche corretamente a lacuna do texto apresentado (...63...) .
Alternativas
Q2243757
Inglês Advérbios e conjunções | Adverbs and conjunctions , Advérbios de: lugar, modo, tempo e freqüência | Adverbs of: place, manner, time and frequency ,
Ano: 2003 Banca: FCC Órgão: CVM Prova: FCC - 2003 - CVM - Analista - Normas Contábeis e de Auditoria |
Q2243757 Inglês
      Michael R. Bloomberg is the 108th Mayor of the City of New York. He was born on February 14, 1942 to middle class parents in Medford, Massachusetts, where his father was the bookkeeper at a local dairy. Mayor Bloomberg's thirst for information and fascination with technology was evident at an early age, and led him to Johns Hopkins University, where he parked cars and took out loans to finance his education. After his college graduation, he gained an MBA from Harvard and in the summer of 1966, he was hired by Salomon Brothers to work on Wall Street.

    He quickly advanced through the ranks, and became a partner in 1972. Soon after, he was supervising all of Salomon's stock trading, sales and later, its information systems. He was fired in 1981 after another company acquired Salomon. Michael Bloomberg used his stake from the Salomon sale to start his ...39... company, an endeavor that would revolutionize the way that Wall Street ....40.... business. As a young trader, he had been amazed at the archaic nature in which information was stored. When he needed to see how a stock had been trading three weeks earlier, he had to find a copy of the Wall Street Journal from the date in question, and the records system consisted of clerks penciling trades in oversize ledgers. ...41... , he created a financial information computer that would collect and analyze different combinations of past and present securities data and deliver it immediately to the user.

       In 1982, Bloomberg LP sold 20 subscriptions to its service; 20 years ....42... , Bloomberg LP has over 165,000 subscribers worldwide. As the business proved its viability, the company branched out and in 1990 Bloomberg LP entered the media business, launching a news service, and then radio, television, Internet, and publishing operations.
   
         Nearly 20 years after its founding, Bloomberg LP now employs more than 8,000 people − including 2,500 in New York City − in more than 100 offices worldwide. As the company enjoyed tremendous growth, Michael Bloomberg dedicated more of his time and energy to philanthropy and civic affairs. His desire to improve education, advance medical research and increase access to the arts, has provided the motivation for much of his philanthropy.

         The Mayor served as the Chairman of the Board of Trustees of Johns Hopkins University until May 2002. Recently, he was honored by Johns Hopkins University, when its School of Hygiene and Public Health was renamed "The Bloomberg School of Public Health," a tribute to his leadership and use of philanthropy to improve the human ....43... .

     In 1997, Michael Bloomberg published his autobiography, Bloomberg by Bloomberg. All of the royalties from sales of the book are donated to the Committee to Protect Journalists.

(Adapted from http://home.nyc.gov/portal/index.jsp?pageID=nyc_mayor_bio&catID=119 4&cc=unused1196&rc=1194&ndi=-1)
Para responder à questão, assinale, na folha de respostas, a letra correspondente à alternativa que preencha corretamente a lacuna do texto apresentado (...42...). 
Alternativas
Q2242136
Inglês Advérbios e conjunções | Adverbs and conjunctions ,
Ano: 2003 Banca: FCC Órgão: CVM Prova: FCC - 2003 - CVM - Analista - Planejamento e Execução Financeira |
Q2242136 Inglês
The hard cell

The hard cell Thanks to politics, stem cell research in the United States is suffering. But not so in Sweden, which is poised to capture what could be the biggest new market to hit biotech in a decade.

By Stephan Herrera
February 13, 2003

New York, January 1, 2006:
Sweden announces that one of its biotechnology companies is the first in the world to enter clinical trials with a new drug that could cure Alzheimer's disease. Four years ago this type of research was all but stopped in the United States by political and ethical questions − which is ...61... Sweden now seems in the best position to capture a $25 billion market.

      Any day now, the U.S. Congress is expected to pass a sweeping new law that could dramatically inhibit researchers from working with stem cells taken from human embryos. Such cells, which can be used to grow a whole host of new cells and organs, could fundamentally change the way we treat heretofore intractable maladies like Alzheimer's disease, Parkinson's disease, cancer, stroke, liver failure, and heart disease. The only problem is that these cells by definition are derived from human embryos, many of which are cloned or come from unused fetuses collected at fertility clinics. The argument, from a certain segment of the American political spectrum, is that ....62... methods are morally wrong. They are ....63... a form of abortion or an activity that could eventually lead to human cloning.

      Those working in stem cell research say the short-term effect of the legislation will be to further chill all forms of scientific inquiry and commercialization efforts in the field. Entrepreneurs and investors are already eschewing such research − in large part because of the additional uncertainty and risk that politics introduce.

      Of the nearly 50 private stem cell companies in the United States, only a handful are still viable. Meanwhile, across the Atlantic, Sweden has avoided many of the political and ethical quagmires surrounding this type of research. It currently has 40 private stem cell companies, a number that's growing. Sweden's leading research universities have 32 percent of the world's stem cell inventory, close on the heels of the United States' 35 percent.

        Sweden, say analysts, is now in the best position to capture a worldwide market for drugs based on stem cell therapies that could grow to $25 billion in the next three to five years − nearly equal to the whole biotech industry at present. This estimate doesn't even address the market for stem cells capable of repairing damaged vital organs like the brain, heart, and kidneys. If the United States offers an object lesson of what can happen when scientific inquiry and investment capital fall victim to politics, Sweden and its leading stem cell startup, NeuroNova, offer the opposite example. How odd that the United States, which for generations has been the envy of the world for its progressive views of science and commercialization, should now have a biomedical climate chillier than a Swedish winter.

       One company feeling a lot of pain is StemCells, which at first glance seems to have it all: founding scientists include Stanford's Dr. Weissman and Fred Gage of the Salk Institute in La Jolla, California. An equally well-regarded expert in the treatment of Alzheimer's, Dr. Gage spent five years in Sweden as a researcher and now sits on a national committee on stem cell research there. The firm's chairman is Roger Perlmutter, Amgen's head of research.

    Yet over the past two years, none of management's efforts to help investors and even critics reconsider the stem cell field have worked. At press time, the stock was thinly traded and sitting in the neighborhood of 50 cents. With less than $15 million in cash, the company likely won't exist at this time next year. (CEO Martin McGlynn, who joined the firm in January 2001, would not talk to Red Herring, despite repeated efforts.)

      Some observers on Wall Street are asking, If StemCells can't make it, who can? Geron, the only other publicly held stem cell firm to speak of, is in a fix, too. The company's stock price is also moribund, at $3.85 per share. Thanks to some capital infusions a few years ago, when money came easy, Geron still has $40 million on hand, but by the end of next year, that too will likely be gone. Once a media darling, Geron focuses on diagnostic tests and drugs derived from stem cells, a strategy that's not going well. For the nine months ended last September, revenue fell 68 percent to $955,000 and net loss widened 18 percent to $26.7 million. The company's financials were also hit hard after it terminated an agreement with Pharmacia and acquired research technology from Lynx Therapeutics, which Geron bought in a desperate attempt to be seen as something more than just a stem cell company.

     The situation is quite different, however, for Sweden's NeuroNova, which has 30 academic partners and a staff of 20. NeuroNova is working on ways to inject stem cells into the human brain to trigger a process called neurogenesis (the growth of new neural cells), which could combat diseases like Parkinson's, Alzheimer's, and even schizophrenia.

       If NeuroNova is the first to develop a drug capable of treating one of several central nervous system disorders − by far the most lucrative after heart disease products − it will have done so not because it raised more money or got more media buzz than the rest. It will have succeeded because the science is solid, and academe, government, and the investment community are supportive. Meanwhile, the United States will look on with envy and wonder how it, a country known for its entrepreneurial innovation, ever got so short-sighted.

(Adapted from
http://www.redherring.com/investor/2003/02/biotech021303.html)

Instruções: Para responder a questão, assinale, na folha de respostas, a letra correspondente a alternativa que preenche corretamente a lacuna do texto apresentado.
Alternativas
Q2242132
Inglês Advérbios e conjunções | Adverbs and conjunctions , Os advérbios (grau, a finalidade, contraste ...) | Adverbs (degree, purpose, contrast...) ,
Ano: 2003 Banca: FCC Órgão: CVM Prova: FCC - 2003 - CVM - Analista - Planejamento e Execução Financeira |
Q2242132 Inglês
From the IPO to the First Trade: Is Underpricing Related to the Trading Mechanism?

Sonia Falconieri, Albert Murphy and Daniel Weaver

        As documented by a vast empirical literature, IPOs are characterized by underpricing. Most of the theoretical literature has linked the size of underpricing to the IPO procedure used on the primary market. In this paper, by using a matched sample of NYSE and Nasdaq IPOs, we show that the size of underpricing also depends on the trading method used in the IPO aftermarket.

         There are two major methods of opening trading of initial public offerings (IPOs) in the U.S. The NYSE is an order-driven market ....56... a call auction allows supply and demand to be aggregated (at one location) prior to the start of trading. .....57.... , Nasdaq is a quote-driven market. Dealers can only specify their best quotes, and participants have KK 58 idea of supply and demand away from the inside quotes.

      We propose a new proxy for ex ante uncertainty of firm value and test it. Our results show that there is a larger level of uncertainty at the beginning of trading on Nasdaq than on the NYSE. This in turn is associated with larger levels of underpricing for Nasdaq IPOs. We suggest that this may be due to the different informational efficiency of the two trading systems.

(http://www.nyse.com/marketinfo/p1020656068262.html?displayPage=%
2Fmarketinfo%2Fmarketinfo.html)
Instruções: Para responder à questão, assinale, na folha de respostas, a letra correspondente à alternativa que preenche corretamente a lacuna do texto apresentado.
Alternativas
Q2238992
Inglês Adjetivos | Adjectives , Advérbios e conjunções | Adverbs and conjunctions , Substantivos e compostos | Nouns and compounds , Preposições | Prepositions , Verbos | Verbs
Ano: 2023 Banca: CESPE / CEBRASPE Órgão: MPE-RO Prova: CESPE / CEBRASPE - 2023 - MPE-RO - Analista de Redes e Comunicação de Dados |
Q2238992 Inglês
Text 2A7

         Artificial intelligence (AI) is arguably the most rapidly advancing technology humans have ever developed. A year ago, you wouldn’t often hear AI come up in a regular conversation, but today it seems there’s constant talk about how generative AI tools like ChatGPT and DALL-E will affect the future of work, the spread of information, and more. A major question that has thus far been almost entirely unexamined is how this AI-dominated future will affect people’s minds.
           
           There’s been some research into how using AI in their jobs will affect people mentally, but there isn’t yet an understanding of how simply living amongst so much AI-generated content and systems will affect people’s sense of the world. How is AI going to change individuals and society in the not-too-distant future?

            AI will obviously make it easier to produce disinformation. That will affect people’s sense of trust as they’re scrolling on social media. AI can also allow someone to imitate your loved ones, which further erodes people’s general ability to trust what was once unquestionable.

Internet: <wired.com> (adapted). 
In the context of the first sentence of the second paragraph of text 2A7, the word “understanding” is grammatically classified as 
Alternativas
Q2231441
Inglês Adjetivos | Adjectives , Advérbios e conjunções | Adverbs and conjunctions , Substantivos e compostos | Nouns and compounds , Pronomes | Pronouns , Verbos | Verbs
Ano: 2023 Banca: FURB Órgão: Prefeitura de Doutor Pedrinho - SC Prova: FURB - 2023 - Prefeitura de Doutor Pedrinho - SC - Professor (Inglês) |
Q2231441 Inglês
(§1º)Budelli Island is part of the La Maddalena Archipelago and is home to Spiaggia Rosa - a stretch of pink sand that's been protected by the Italian government since 1992.

(§2º)The pink shade is caused by the crushed shells of a micro-organism mixing with the sand when it dies. But when the beach started to lose its rose-tinted hue because of over-tourism, visitors were banned in a bit to protect the pink sand.

(§3º)The colour has since returned but a new wave of unauthorised daytrippers are threatening the pink shores. While it is strictly forbidden to step foot on the beach, holidaymakers are able to admire the pink sand from the safety of a boat. But according to one expert, some holidaymakers are flouting the ban.

(§4º)In an article in the Times, Fabrizio Fonnesu, director of the Maddalena archipelago national park said: "The beach is again in danger as people arrive by boat, clamber up the beach, then post photos, which allow us to fine them up to 500 euros (£430)."

(§5º)Tourists who've attempted to take Sardinia's pink sand away as a souvenir can up fined up to 3,500 euros (£3,007). And according to the Guardian, a couple were fined 1,000 euros (£860) in 2001 after they were caught filling a plastic bottle with sand.

(§6º)Brits who want to visit the island will need to book themself onto a private boat tour or a ferry service to glimpse this secluded spot from afar. Other beaches on the island have also brought in measures to minimise the impact of tourists. Only 1,600 people can visit Cala Sisine while Santa Maria Navarrese only permits 1,300 euros.

(§7º)Fewer still are able to visit Cala Mariolu, with only 550 people allowed in per day and each having to pay a 1 euro fee. Elsewhere, Pelosa Beach has banned towels and asked visitors to instead bring mats which gather less sand. Anyone visiting will have to pay 3.50 euros.

(§8º)Meanwhile, tourists wanting to visit the beaches of Cala Coticcio and Cala Brigantina in the archipelago of La Maddalena will have to pay 3 euros per person for access each day after new rules were brought in. The archipelago itself is a national park and only accessible with a guide, which will cost 25 euros for five hours.

(§9º)And anyone caught visiting the archipelago without a guide could face prosecution. Just 60 people will be permitted on each beach per day, as the local authorities look at ways to protect the sites from the impact of tourism.

(§10º)Slots must be booked in advance by contacting a local guide but it is hoped that an app will be launched soon. Here are several other pink beaches holidaymakers can visit across Europe - and one's in the UK. And a beach in the Canary Islands even has sand that looks like popcorn, due to the shape of the coral.

itssfnneed
w.thesun.co.uk/travel/22667535/pink-beach-italy-bundelli-tourists-fined/
Identify the grammatical class of the word "unauthorised" (§3º) in the text: 
Alternativas
Q2217914
Inglês Advérbios e conjunções | Adverbs and conjunctions ,
Ano: 2023 Banca: CESGRANRIO Órgão: Banco do Brasil Prova: CESGRANRIO - 2023 - Banco do Brasil - Agente Comercial - Prova C |
Q2217914 Inglês




Available at: https://www.forbes.com/advisor/personal-finance/ how-to-teach-your-kids-good-money-habits/ Retrieved on: Jan. 2, 2023. Adapted.
In the passage of paragraph 3, “An allowance can accomplish that. However, you should consider requiring your kids to do certain tasks to earn their allowance”, the term “however” establishes the idea of
Alternativas
Q2210441
Inglês Advérbios e conjunções | Adverbs and conjunctions , Preposições | Prepositions , Pronomes | Pronouns , Pronomes interrogativos | Question words
Ano: 2023 Banca: FUNDATEC Órgão: Prefeitura de Espumoso - RS Prova: FUNDATEC - 2023 - Prefeitura de Espumoso - RS - Professor de Séries Finais - Língua Inglesa |
Q2210441 Inglês

Fill out the gaps below with one the following words: that / where / which / who.


1. That’s the store ___ they buy their shoes.

2. The book, ___ we’ve been reading at school, was written long ago.

3. These are the directors and movies ___ I like.

4. Marie Curie is the woman ___ discovered radium.


Mark the alternative that fills out, correctly and respectively, the gaps in the sentences above. 

Alternativas
Q2210438
Inglês Advérbios e conjunções | Adverbs and conjunctions , Posição dos advérbios | Position of adverbs ,
Ano: 2023 Banca: FUNDATEC Órgão: Prefeitura de Espumoso - RS Prova: FUNDATEC - 2023 - Prefeitura de Espumoso - RS - Professor de Séries Finais - Língua Inglesa |
Q2210438 Inglês

Stop Wasting Time: A 15-minute Planning Session That Will Save You Hours







(Available at: https://www.classycareergirl.com/5-simple-time-management-tips-for-a-great-week/– textespecially adapted for this test).
In which of the sentences below the position of the adverb in bold is INCORRECT? 
Alternativas
Q2209855
Inglês Advérbios e conjunções | Adverbs and conjunctions , Posição dos advérbios | Position of adverbs ,
Ano: 2023 Banca: FUNDATEC Órgão: Prefeitura de Maçambara - RS Prova: FUNDATEC - 2023 - Prefeitura de Maçambara - RS - Professor Anos Finais do Ensino Fundamental – Inglês |
Q2209855 Inglês
Considering the order of the words, which of the sentences below is INCORRECT?
Alternativas
Q2209849
Inglês Advérbios e conjunções | Adverbs and conjunctions , Advérbios de: lugar, modo, tempo e freqüência | Adverbs of: place, manner, time and frequency , Interpretação de texto | Reading comprehension ,
Ano: 2023 Banca: FUNDATEC Órgão: Prefeitura de Maçambara - RS Prova: FUNDATEC - 2023 - Prefeitura de Maçambara - RS - Professor Anos Finais do Ensino Fundamental – Inglês |
Q2209849 Inglês


Try these expert tips for a safer solo trip




(Available at: https://news.airbnb.com/try-these-expert-tips-for-a-safer-solo-trip/ – text especially adapted for this text).

The underlined word “never” (l. 25) is a(an):
Alternativas
Q2208075
Inglês Advérbios e conjunções | Adverbs and conjunctions , Advérbios de: lugar, modo, tempo e freqüência | Adverbs of: place, manner, time and frequency ,
Ano: 2023 Banca: JVL Concursos Órgão: Prefeitura de São José do Piauí - PI Prova: JVL Concursos - 2023 - Prefeitura de São José do Piauí - PI - Professor de Anos Finais - Língua Inglesa |
Q2208075 Inglês

Look at the map below and complete the sentence with the correct word. Choose the CORRECT answer. 


Imagem associada para resolução da questão


“The gas station is _________ the stadium.” 

Alternativas
Q2206461
Inglês Advérbios e conjunções | Adverbs and conjunctions , Advérbios de: lugar, modo, tempo e freqüência | Adverbs of: place, manner, time and frequency , Os advérbios (grau, a finalidade, contraste ...) | Adverbs (degree, purpose, contrast...) , Interpretação de texto | Reading comprehension
Ano: 2023 Banca: FGV Órgão: SEDUC-TO Prova: FGV - 2023 - SEDUC-TO - Professor da Educação Básica - Professor Regente Letras - Inglês |
Q2206461 Inglês
Text VI


https://www.glasbergen.com/image-
search/cartoons/search/ALPHABET%20SOUP/page/2
The adverb “really” in the first sentence indicates
Alternativas
Q2206458
Inglês Advérbios e conjunções | Adverbs and conjunctions , Advérbios de: lugar, modo, tempo e freqüência | Adverbs of: place, manner, time and frequency , Os advérbios (grau, a finalidade, contraste ...) | Adverbs (degree, purpose, contrast...) , Interpretação de texto | Reading comprehension
Ano: 2023 Banca: FGV Órgão: SEDUC-TO Prova: FGV - 2023 - SEDUC-TO - Professor da Educação Básica - Professor Regente Letras - Inglês |
Q2206458 Inglês
Text V 

A New Buzz In Teaching And Learning: ChatGPT
   […]
   We live in a world constructed by data and content. With theavailability of AI chatbots, we can generate tons of them, with just a few taps on our keyboards. Undeniably, ChatGPT is a powerful and versatile language model, with the potential to revolutionize how we learn and interact with machines. As the Chinese idiom says, "Water can carry a boat but can also overturn it." This expression is a reminder that everything has its pros and cons, and it's therefore important to remain aware of potential risks and take the necessary precautions. With this in mind, it’s of the utmost importance to use this tool in a responsible and ethical manner, to ensure that the output aligns with the desired use cases.

From: https://elearningindustry.com/a-new-buzz-in-teaching-and-learning-chatgpt
“Therefore” in “it's therefore important” signals a(n)
Alternativas
Q2206412
Inglês Advérbios e conjunções | Adverbs and conjunctions , Advérbios de: lugar, modo, tempo e freqüência | Adverbs of: place, manner, time and frequency , Interpretação de texto | Reading comprehension , Vocabulário | Vocabulary
Ano: 2023 Banca: Creative Group Órgão: Prefeitura de Itá - SC Prova: Creative Group - 2023 - Prefeitura de Itá - SC - Professor de Inglês |
Q2206412 Inglês
The Latest Avatar 3

Adapted from the internet

     The latest Avatar 3 updates have confirmed that Captain Mick Scoresby (Brendan Cowell) will return for Avatar 3. This could spell either good news or bad for the next Avatar instalment, as his storyline was similar to Quaritch’s in that it was presumed he bit the dust, only to come back for another sequel. In addition, Zoe Saldana recently gave a filming update while speaking to Entertainment Tonight. While director James Cameron had stated that filming is nearly done for Avatar 3 back in 2020, Saldana reported to ET that the crew was going back to film for the summer, and that the process was “70% done there”.
      That being said, conflicting Avatar 3 updates come from a Q&A session with producer John Landau, who said that Avatar 3 and the first act of Avatar 4 were filmed simultaneously with Avatar 2. Either way, the consensus is the sequel is nearly done with the filming process. In the same Q&A, Landau revealed that Avatar 3 will introduce two new Na’vi cultures. "But we're going to meet at least two new clans in the next movie, culturally, and go on and on as we continue that," Landau said. Likely one of these new cultures will be the fire Na’vi, of which Oona Chaplin's Varang will be a part of.
       In addition, other Avatar 3 updates have confirmed two major character returns. The first is that of Avatar: The Way of Water's breakout character Payakan, the gentle and intelligent Tulkun. In an interview with The Wrap, Landau confirmed that Payakan would be back for Avatar 3, saying, "I always viewed Payakan a little bit like Lassie. And I would say this is a story like a boy and his dog, and they’re both outcasts, and they need each other." In the same interview, Landau also stated that the Avatar secondary villain Parker Selfridge (Giovanni Ribisi), who was absent for the sequel, would come back in a major way for Avatar 3. 
The word “likely”, in bold type in the text (paragraph 2) is 
Alternativas
Q2204974
Inglês Advérbios e conjunções | Adverbs and conjunctions , Interpretação de texto | Reading comprehension , Vocabulário | Vocabulary ,
Ano: 2023 Banca: FGV Órgão: Prefeitura de Jaboatão dos Guararapes - PE Prova: FGV - 2023 - Prefeitura de Jaboatão dos Guararapes - PE - Professor 2 - Língua inglesa |
Q2204974 Inglês
Text III

Teaching a child to read

Imagery first: the colors primary
Familiar as the sun; the purpose sure –
To hear, to smell, to feel, to taste, to see.
The mind will enter by another door.

The verb is next: we are the rain that falls,
The frog that sees a cricket as it leaps,
The robin that flaps its wings and calls,
The fish that swims, the animal that creeps.

The third is narrative, the moving spell
Of syntax that ad-libs the myths of time.
Alas, we learn before the wishing well
Has dried how words become a hill to climb.

The fourth is symbol: goodness, beauty, love.
This is the time of quarrel, tears and pain.
Sowing the dragons’ teeth, we bob and weave
Until we bring the simple back again.

By Allen Kanfer. Source: https://www.poetryfoundation.org/ poetrymagazine/browse?contentId=28478 Glossary: to ad-lib: If you ad-lib something in a play or a speech, you say something which has not been planned or written beforehand. (https://www.collinsdictionary.com/dictionary/english/ad-lib)
The conjunction in “as it leaps” has the same function as in the sentence
Alternativas
Q2201497
Inglês Adjetivos | Adjectives , Advérbios e conjunções | Adverbs and conjunctions , Substantivos e compostos | Nouns and compounds , Verbos | Verbs
Ano: 2023 Banca: IBFC Órgão: SEED-PR Prova: IBFC - 2023 - SEED-PR - DOCÊNCIA DOS COMPONENTES CURRICULARES DA MATRIZ - LÍNGUA ESTRANGEIRA INGLÊS |
Q2201497 Inglês

Text 2 – Computers

(Text adapted from History of Computing. Retrieved from

https://www.cs.utexas.edu/~mitra/csFall2006/cs 303/lectures/history.html)


When you hear the term computers, it’s difficult to imagine different devices from a laptop or a small desktop. Believe it or not, they weren’t always like they are today. They used to be very large and heavy, sometimes as big as an entire room. Some technology professors historically define computers, as “a device that can help with computations”. The word computation involves counting, calculating, adding, subtracting, etc. The modern definition of a computer is a little wider, because in our day and age, computers store, compile, analyze and compute an enormous amount of information. Ancient computers were very interesting. Actually, the first computer may have been located in Great Britain, at Stonehenge. It is a man-made circle of large stones. Citizens used it to measure the weather and forecast the change of seasons. Some specialists say that another ancient computer is the abacus. It was used by the early Romans, Greeks, and Egyptians to count and calculate. Even though they are no longer in use, certainly, these early devices are fascinating. Computers are embedded in our history and some people say that we are completely dependent of them. No matter the complexity of the task, easy or difficult, some people can’t do anything without them. Do you contest or share this opinion? 

The formation-ing in "Computing involves counting a lot of data" is correct. Check the alternative that explains the -ing formation of 'counting'. 
Alternativas
Respostas
101: D
102: D
103: D
104: B
105: D
106: D
107: E
108: C
109: A
110: C
111: A
112: E
113: B
114: A
115: A
116: C
117: A
118: C
119: D
120: E
www.qconcursos.com